DRI Successfully Transplants BioHub Wendy Peacock

DRI Successfully Transplants BioHub into First Diabetes Patient

Bydiabetesknow

DRI Successfully Transplants BioHub. Diabetes Research Institute has successfully transplanted their bioengineered mini-organ called the DRI BioHub into the omentum of the first patient (Wendy Peacock).

A very close friend of mine contacted me with this exciting news. Her very young daughter lives with type 1 diabetes and is using pump therapy so this could possibly be yet another option for her child to be cured as well as thousands of others who suffer from this condition.

Let’s hope the FDA-approved Phase I/II clinical trial for the BioHub to be transplanted into the new omentum site works as planned to mimic the native pancreas to restore natural insulin production in people with type 1 diabetes. Read full article here!

Share this post:

Share on Pinterest Share on LinkedIn Share on Reddit

I'm a type 1 diabetic with diabetes knowledge in t1d and t2d, as well as nutrition and low-carb keto diet information, fitness and exercise programs to help keep you in optimal diabetes health. Take advantage of our diabetic health tools for a healthier lifestyle!

Similar Posts

Prescription drug could eliminate insulin - Biospace.com

Vancouver Doctor Leads Groundbreaking Diabetes Research (Drug)

Bydiabetesknow

Previously Published on BioSpace.com – Prescription drug could eliminate insulin dependence in people with type 1 diabetes. Newly diagnosed patients sought for clinical trial. 300,000 Canadians are living with type 1 diabetes (T1D). There is no known cause or cure. The number of new cases is increasing by approximately 5% every year in Canada. With an annual…

Tattoo for diabetics

Get A Tattoo Instead of Needle Pricks for Diabetics

Bydiabetesknow

Here’s a potential game-changer for diabetics to end needle pricks to test their blood sugar level and it comes in a tattoo. It’s actually a temporary tattoo that consists of patterned electrodes that send a mild electrical current into the skin for 10 minutes which forces ions carrying glucose molecules to the surface. The electrodes…

Genprex Announces Groundbreaking Gene Therapy to Treat Type 1 Diabetes

Genprex Announces Groundbreaking Gene Therapy to Treat Type 1 Diabetes

Bydiabetesknow

Previously Published on Genprex.com — Genprex, Inc. (“Genprex” or the “Company”) , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that data highlighting the potential of Genprex’s gene therapy for Type 1 diabetes is being presented by its research collaborators at the University of Pittsburgh (Pitt) at the 16th International…

Artificial Pancreas

Artificial Pancreas Shows Promise in Type 1 Diabetes

Bydiabetesknow

The Artificial Pancreas is a smart idea and does show promise in controlling blood sugars for type 1 diabetics who are currently using insulin pumps. The system uses a modified iPhone connected to a glucose monitor and pumps that deliver the insulin and glucagon. It mimics the natural release of daily insulin and eliminates injections….

FDA Endorses Teplizumab for Delaying Type 1 Diabetes

FDA Endorses Teplizumab for Delaying Type 1 Diabetes

Bydiabetesknow

Previously Published on Medscape.com – A US Food and Drug Administration (FDA) advisory panel has voted narrowly to recommend approval of the monoclonal antibody teplizumab (Tzield,Provention Bio) for the delay of type 1 diabetes in at-risk individuals. (FDA Endorses Teplizumab) The 10-7 vote of the FDA’s Endocrinologic and Metabolic Drugs advisory committee on May 27 reflected a…

Implantable Micro-Pancreas
|

Implantable Micro Pancreas by Betalin Therapeutics

Bydiabetesknow

Israeli firm Betalin Therapeutics has an implantable micro-pancreas that can produce insulin in patients with diabetes. Engineered Micro Pancreas The biological scaffolding combined with insulin producing cells is an engineered micro-pancreas. Therefore, implanted into a person during a minimally invasive procedure. Betalin‘s head researcher Avi Treves says the implanted device has the ability to produce insulin in…